Skip to main content

Table 1 Patient characteristics

From: Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)

  

Age (Years)

Age at 1st occurrence of symptoms (Years)

Age at 1st ADHD-diagnosis (Years)

 

N (%)

Mean

SD

Mean

SD

Mean

SD

All patients

421 (100)

11.1

2.74

4.0

2.03

8.1

2.59

Boys

338 (80.3)

11.0

2.70

4.0

1.94

7.9

2.54

Girls

83 (19.7)

11.6

2.87

4.3

2.35

8.8

2.70

Combined subtype*

278 (66.0)

10.6

2.58

3.7

1.92

7.6

2.42

Predominantly inattentive subtype*

124 (29.5)

12.4

2.59

4.7

1.93

9.2

2.58

Predominantly hyperactive-impulsive subtype*

6 (1.4)

8.6

2.33

4.2

2.01

6.6

2.22

ADHD, not otherwise specified *

13 (3.1)

11.7

3.08

4.8

3.42

9.6

2.30

  1. * According to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
  2. Abbreviations: SD = standard deviation.
Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000